We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIOTECH FIRMS MAY BE FIRST TO MARKET FOLLOW-ON BIOLOGICS
BIOTECH FIRMS MAY BE FIRST TO MARKET FOLLOW-ON BIOLOGICS
June 25, 2004
Existing biotech brand firms, rather than traditional generic drugmakers, likely will be the first to go after the nearly $10 billion worth of biologic products going off patent in the next few years, experts say.